Our study revealed that OMD promoted BMP2 protein and enhanced the binding of BMP2 to its receptor BMPR1A, resulting in the upregulation of RUNX2, which further promoted OMD mRNA expression via binding to OMD promoter. This evidence concerns the gene BMP2 and occult macular dystrophy.